TNFA•benzinga•
TNF Pharmaceuticals Completed FDA-Recommended Study Of Isomyosamine, Demonstrating Clinical Safety Throughout 13 Weeks Of Treatment At All Dose Levels Evaluated
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 15, 2025 by benzinga